| __timestamp | Catalyst Pharmaceuticals, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 396000000 |
| Thursday, January 1, 2015 | 11801342 | 364000000 |
| Friday, January 1, 2016 | 11369941 | 376000000 |
| Sunday, January 1, 2017 | 11375237 | 382000000 |
| Monday, January 1, 2018 | 19919204 | 432000000 |
| Tuesday, January 1, 2019 | 18842752 | 457000000 |
| Wednesday, January 1, 2020 | 16496715 | 463000000 |
| Friday, January 1, 2021 | 16936000 | 508000000 |
| Saturday, January 1, 2022 | 19789000 | 539000000 |
| Sunday, January 1, 2023 | 93150000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Zoetis Inc. and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Zoetis consistently invested significantly more in R&D, with a peak in 2023, where their spending reached approximately $614 million, marking a 55% increase from 2014. In contrast, Catalyst Pharmaceuticals showed a more modest growth trajectory, with a notable spike in 2023, where their R&D expenses surged to $93 million, a remarkable 820% increase from 2014. This disparity highlights Zoetis's commitment to maintaining a robust pipeline, while Catalyst's recent surge suggests a strategic pivot towards innovation. As the pharmaceutical landscape continues to shift, these investments will likely play a pivotal role in shaping the future of both companies.
Comparing Innovation Spending: Pfizer Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs Catalyst Pharmaceuticals, Inc.
R&D Insights: How Ascendis Pharma A/S and Catalyst Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for MorphoSys AG and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Catalyst Pharmaceuticals, Inc. and Wave Life Sciences Ltd.
R&D Insights: How Catalyst Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Catalyst Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds